AFPM Senior Petrochemical Advisor Jim Cooper answered a few questions to help illuminate some of the ways that petrochemicals—and the industries that produce them—are working to protect people from the coronavirus.
AFPM Senior Petrochemical Advisor Jim Cooper talks about the central role of petrochemicals in health care, and why the petrochemical industry is considered critical infrastructure.
WASHINGTON, D.C. – AFPM released the following statement today in response to the President signing into the law the reauthorization of the Chemical Facility Anti-Terrorism Standards program.
Over the last 20 years, I have seen an increasing number of women joining the petrochemical industry which is a great thing. However, women still only make up 25 percent of the petrochemical workforce...
It’s been two and a half years since Congress granted the Department of Homeland Security’s Chemical Facility Anti-Terrorism Standards (CFATS) program long-term authorization.
WASHINGTON, D.C. – Today, amid concerns about the spread of COVID-19, the American Fuel & Petrochemical Manufacturers has made the difficult decision to cancel its Annual Meeting slated to take place March 22-24 in Austin, Texas, and the International Petrochemical Conference scheduled for March 29-31 in New Orleans.
Every day, AFPM members make products that improve our lives and contribute to human progress — including fuels like gasoline, diesel and jet fuel that facilitate access to vital health services, and petrochemicals used as building blocks to create healthcare equipment, devices and technologies.
Athletes gathering for the winter Paralympics in South Korea this month are remarkable examples of how people overcome challenges – and new technologies are increasingly helping these impressive athletes push their limits by doing more, going faster or going farther.
Earlier this month, researchers at the University of Sydney and Harvard announced the development of a new surgical glue called “MeTro”, which promises to revolutionize the treatment of wounds both on...
At only 21 years old, Matt was diagnosed with heart valve disease — a condition he was able to manage with the help of doctors and medicines for nearly a decade.